Trials / Conditions / Resectable Glioblastoma
Resectable Glioblastoma
3 registered clinical trials studyying Resectable Glioblastoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Gliob NCT07301268 | Mayo Clinic | Phase 2 |
| Recruiting | ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or As NCT07089641 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Recruiting | Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblas NCT06090903 | Jonsson Comprehensive Cancer Center | N/A |